Hochstein-Mintzel V, Hänichen T, Huber H C, Stickl H
Zentralbl Bakteriol Orig A. 1975;230(3):283-97.
The attenuated MVA strain of vaccinia virus was previously shown to be innocuous and immunogenic at intracutaneous injection. It was therefore suggested for clinical trial. Preliminary results in human vaccinees are promising. The present experiments were initiated to study the intramuscular injection of the vaccine as a preferable route of administration. Histological examination was done in rabbits and monkeys. At the site of injection there were but minor inflammatory reactions considerably less pronounced than after the injection of commercial tetanus vaccine which was used for comparison. Intramuscular immunization with strain MVA repeated twice protected rabbits against an intravenous challenge with vaccinia strain Elstree; monkeys were protected against experimental smallpox. Intramuscular immunization with attenuated smallpox vaccine is suggested for clinical trial.
痘苗病毒减毒MVA株先前已证明在皮内注射时无毒且具有免疫原性。因此建议进行临床试验。人体疫苗接种的初步结果很有前景。开展本实验是为了研究将疫苗肌肉注射作为更优给药途径。对兔子和猴子进行了组织学检查。在注射部位仅有轻微炎症反应,比用于对照的市售破伤风疫苗注射后明显轻得多。用MVA株进行两次重复肌肉免疫可保护兔子免受痘苗病毒Elstree株静脉攻击;猴子可免受实验性天花感染。建议对减毒天花疫苗进行肌肉免疫的临床试验。